These are not hypothetical problems
This June, Eli Lilly initiated six lawsuits, following 10 other lawsuits that the pharmaceutical company began last fall
They should be avoided in individuals with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome
Its like a furnace that keeps your body running
Tirzepatide is the active ingredient in Mounjaro and Zepbound, medications that are dual-action GLP-1/GIP antagonists that have been shown to help people lose an average of 25% of their body weight.* A Zealthy provider will review your healthcare assessment & prescribe compounded tirzepatide, if appropriate
Luckily, we now have a new class of medications that are extremely effective for weight loss, have minimal and very tolerable side effects, and can positively impact other aspects of your health